Cas:161940-20-1 methyl 4-[(2-methylpropan-2-yl)oxycarbonylamino]thiophene-3-carboxylate manufacturer & supplier

Chemical Name:methyl 4-[(2-methylpropan-2-yl)oxycarbonylamino]thiophene-3-carboxylate

CAS.NO:161940-20-1

Synonyms:QC-5923;Methyl 4-Boc-aminothiophene-3-carboxylate

Molecular Formula:C₁₁H₁₅NO₄S

Molecular Weight:257.30600

HS Code:2934999090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:316.165ºC at 760 mmHg

Density:1.25g/cm3

Index of Refraction:1.557

PSA:92.87000

Exact Mass:257.07200

LogP:2.95470

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like QC-5923 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Methyl 4-Boc-aminothiophene-3-carboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Methyl 4-Boc-aminothiophene-3-carboxylate Use and application,Methyl 4-Boc-aminothiophene-3-carboxylate technical grade,usp/ep/jp grade.

Related News: This is particularly important in reducing overall disease burden. Moreover, this strategic decision will not only strengthen our diabetes portfolio but also help consolidate our position as the fastest-growing player in the anti-diabetes segment, Mankind Pharma Director of Marketing Sanjay Koul said in a statement. methyl 4-[(2-methylpropan-2-yl)oxycarbonylamino]thiophene-3-carboxylate manufacturer It has reserves in the direction of APIs and intermediates for lowering blood lipids, lowering blood sugar and anticoagulation. methyl 4-[(2-methylpropan-2-yl)oxycarbonylamino]thiophene-3-carboxylate supplier Secretary of Health Francisco Duque said authorities are working with the Chinese embassy to respectfully handle the remains of the man while following international protocol to contain the disease. methyl 4-[(2-methylpropan-2-yl)oxycarbonylamino]thiophene-3-carboxylate vendor This is particularly important in reducing overall disease burden. Moreover, this strategic decision will not only strengthen our diabetes portfolio but also help consolidate our position as the fastest-growing player in the anti-diabetes segment, Mankind Pharma Director of Marketing Sanjay Koul said in a statement. methyl 4-[(2-methylpropan-2-yl)oxycarbonylamino]thiophene-3-carboxylate factory Only when the drug substance is processed into a pharmaceutical preparation can it become a drug for clinical application.